# DERPC

## Overview
The DERPC gene encodes the DERPC proline and glycine-rich nuclear protein, which is characterized by its abundance of proline and glycine residues. This protein is primarily localized in the nucleus and is implicated in various cellular processes, although its precise biological functions remain to be fully elucidated. DERPC is expressed in multiple tissues, including muscle, testis, liver, ovary, and heart, with notable expression in the prostate. Research suggests that DERPC may function as a tumor suppressor, particularly in prostate cancer, where it has been observed to inhibit cancer cell growth. However, its expression is reduced in renal and prostate tumors, indicating a potential role in tumor suppression (Green2008Loss). Despite these findings, the role of DERPC in other cancers, such as breast cancer, remains ambiguous, as studies have shown no significant association with lobular carcinoma in situ (Green2008Loss). Further research is needed to fully understand the clinical significance and molecular mechanisms of DERPC.

## Function


## Clinical Significance
The DERPC gene, known for its expression in various tissues such as muscle, testis, liver, ovary, and heart, has been studied for its potential role in cancer. It is notably expressed in the prostate, where it has shown inhibitory potential on prostate cancer cell growth. However, its expression is significantly decreased in renal and prostate tumors, suggesting a possible role in tumor suppression in these tissues (Green2008Loss). Despite these findings, no significant association has been found between DERPC expression and lobular carcinoma in situ (LCIS) of the breast, indicating that its role in breast cancer remains unclear (Green2008Loss).

The study of DERPC in the context of LCIS revealed no difference in its expression between LCIS and normal breast tissue, suggesting that DERPC may not be involved in the pathogenesis of this specific type of breast cancer (Green2008Loss). The lack of commercial antibodies has limited the investigation of DERPC protein expression, which could provide further insights into its clinical significance (Green2008Loss). Overall, while DERPC shows potential as a tumor suppressor in certain cancers, its role in breast cancer and other conditions requires further research.


## References


[1. (Green2008Loss) Andrew R. Green, Sophie Krivinskas, Peter Young, Emad A. Rakha, E. Claire Paish, Desmond G. Powe, and Ian O. Ellis. Loss of expression of chromosome 16q genes dpep1 and ctcf in lobular carcinoma in situ of the breast. Breast Cancer Research and Treatment, 113(1):59â€“66, January 2008. URL: http://dx.doi.org/10.1007/s10549-008-9905-8, doi:10.1007/s10549-008-9905-8. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10549-008-9905-8)